search
Back to results

Evaluation of Anterior Cruciate Ligament Tears Using Diffusion Tractography (TRACTOLCA)

Primary Purpose

ACL Injury, MRI, Tractography

Status
Recruiting
Phase
Not Applicable
Locations
France
Study Type
Interventional
Intervention
tractography MRI sequence protocol
Sponsored by
Centre Hospitalier Universitaire, Amiens
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional other trial for ACL Injury focused on measuring ACL Injury, MRI, tractography

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Age ≥ 18 years old, Patient referred for non-enhanced knee MRI for traumatism. Affiliation to a social security program, Exclusion Criteria: Person under guardianship or curators, Any contraindications to MRI

Sites / Locations

  • CHU Amiens PicardieRecruiting

Outcomes

Primary Outcome Measures

Anisotropy score after tractography MRI sequence
Anisotropy coefficient value is between 0 (isotropic medium) to 1 (fibrillar medium) . Anisotropy coefficient =0 is for total ACL rupture Anisotropy coefficient between 0 end 0.8 is for partial ACL rupture
Correlation between anisotropy coefficient and ACL lesion state
Anisotropy coefficient value is between 0 (isotropic medium) to 1 (fibrillar medium) . Anisotropy coefficient =0 is for total ACL rupture ACL lesion state are No lesion, Partial tear or Complete tear

Secondary Outcome Measures

Full Information

First Posted
March 28, 2023
Last Updated
March 28, 2023
Sponsor
Centre Hospitalier Universitaire, Amiens
search

1. Study Identification

Unique Protocol Identification Number
NCT05806034
Brief Title
Evaluation of Anterior Cruciate Ligament Tears Using Diffusion Tractography
Acronym
TRACTOLCA
Official Title
Evaluation of Anterior Cruciate Ligament Tears Using Diffusion Tractography
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Recruiting
Study Start Date
December 8, 2022 (Actual)
Primary Completion Date
March 2024 (Anticipated)
Study Completion Date
March 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Centre Hospitalier Universitaire, Amiens

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Knees injuries commonly affect the ACL. French current methodology is based on MRI focused on the knee with morphological sequences (T1, DP fat sat) allowing the study of ACL as follows: No lesion / Partial tear / Complete tear. The treatment (kinesitherapy, surgery, no intervention) is defined taking into account several factors such as age, knee laxity, physical activity and outcome of the radiology analysis (partial or complete tear). However, if the classification is straightforward in case of complete tear, it is not possible to establish a quantitative impact on the ACL in case of partial tear. As a consequence, the investigators will analyze the anisotropy coefficient with diffusion tractography. Any patient who undergo a posttraumatic knee MRI at the CHU Amiens Picardie will have an appointment at the 3T "Signa" MRI that has the knee-centric diffusion tractography sequence.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
ACL Injury, MRI, Tractography
Keywords
ACL Injury, MRI, tractography

7. Study Design

Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
297 (Anticipated)

8. Arms, Groups, and Interventions

Intervention Type
Other
Intervention Name(s)
tractography MRI sequence protocol
Intervention Description
tractography MRI sequence protocol does not require injection of contrast agent.
Primary Outcome Measure Information:
Title
Anisotropy score after tractography MRI sequence
Description
Anisotropy coefficient value is between 0 (isotropic medium) to 1 (fibrillar medium) . Anisotropy coefficient =0 is for total ACL rupture Anisotropy coefficient between 0 end 0.8 is for partial ACL rupture
Time Frame
one day
Title
Correlation between anisotropy coefficient and ACL lesion state
Description
Anisotropy coefficient value is between 0 (isotropic medium) to 1 (fibrillar medium) . Anisotropy coefficient =0 is for total ACL rupture ACL lesion state are No lesion, Partial tear or Complete tear
Time Frame
one year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years old, Patient referred for non-enhanced knee MRI for traumatism. Affiliation to a social security program, Exclusion Criteria: Person under guardianship or curators, Any contraindications to MRI
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Wesley BOCQUET, MD
Phone
03 22 03 85 21
Email
bocquet.wesley@chu-amiens.fr
Facility Information:
Facility Name
CHU Amiens Picardie
City
Amiens
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Wesley BOCQUET, MD
Phone
03 22 03 85 21
Email
bocquet.wesley@chu-amiens.fr

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Evaluation of Anterior Cruciate Ligament Tears Using Diffusion Tractography

We'll reach out to this number within 24 hrs